SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
How heart failure risk rises after surgery
Wed June 29th - The development of atrial fibrillation following surgery is an important risk factor for heart failure, researchers report today. More
Brain surgery benefits intracranial pressure
Wed June 29th - Craniectomy for intracranial hypertension offers significant benefit, according to new guidance, triggered by British research. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OTHER NEWS FEEDS OF INTEREST
ENGLEMED HEALTH NEWS

Statins 'worthwhile' despite diabetes link

Friday August 10th, 2012

Cholesterol lowering drugs may aggravate the risk of developing diabetes - but the risks are massively outweighed by the benefits, researchers say today.

In the USA, statin pills carry compulsory warnings about the diabetes risks.

But, according to a new study, people at risk of developing diabetes and taking statins are 39 per cent less likely to develop heart disease than those not taking the drug.

And they were also less likely to die - by a factor of 17 per cent.

This is even though statins increase the risk of their developing diabetes by 28 per cent, according to the report in The Lancet.

The findings come from a study of nearly 18,000 patients. The researchers say they could find no evidence of statins being linked to the development of diabetes in people without risk factors for the disease.

Researcher Professor Paul Ridker, based at Brigham and Women's Hospital, Boston, USA, said: "We believe that most physicians and patients would regard heart attack, stroke and death to be more severe outcomes than the onset of diabetes.

"So we hope that these results ease concern about the risks associated with statin therapy when these drugs are appropriately prescribed – in conjunction with improved diet, exercise and smoking cessation – to reduce patients' risk of cardiovascular disease."

Judy O'Sullivan, of the British Heart Foundation, welcomed the findings.

She said: “This analysis confirms that the benefits of taking statins far outweigh the side effects for the majority of people who need to take them, including those at increased risk of developing diabetes.

“If you’ve been prescribed statins, you should continue to take them. If you have any concerns about your medication, make sure you speak to your doctor.”

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Paul M Ridker, Aruna Pradhan, Jean G MacFadyen, Peter Libby, Robert J Glynn. The Lancet August 10 2012

Tags: Diabetes | Heart Health | North America | Pharmaceuticals | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES